Antimicrobial Resistance Profile of Helicobacter pylori in Shenzhen, China: A Retrospective Study From 2021 to 2024
Abstract
Background: The escalating antibiotic resistance of Helicobacter pylori (H. pylori) poses a significant threat to global public health. Continuous local surveillance is crucial due to substantial geographical and temporal variations in resistance patterns.
Objective: This study aimed to characterize the antimicrobial resistance profile of H. pylori in Shenzhen, China, between 2021 and 2024, and to assess temporal trends and demographic associations.
Methods: We conducted a retrospective analysis of patients who underwent gastroscopy at Shenzhen Hospital of Southern Medical University from March 2021 to October 2024. Gastric mucosal biopsies were collected for H. pylori culture, and antimicrobial susceptibility testing was performed using the agar dilution method.
Results: Among culture-positive isolates, 225 were from treatment-naïve patients and 975 from previously treated patients. Resistance rates in the treatment-naïve vs. previously treated groups were: clarithromycin 17.8% vs. 68.0%, metronidazole 87.1% vs. 97.4%, levofloxacin 11.1% vs. 50.9%, amoxicillin 0.4% vs. 3.1%, and furazolidone 0% vs. 0.1%. No tetracycline-resistant isolates were identified. Significant temporal increases were observed in secondary resistance to clarithromycin, amoxicillin, and metronidazole, as well as in the prevalence of multidrug resistance (all p 0.05). Secondary resistance to clarithromycin, metronidazole, and levofloxacin varied significantly across age groups (p < 0.05), whereas…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.